Currently, Carolyn J. Myers holds the position of President, Chief Executive Officer & Director at FendX Technologies, Inc. Dr. Myers is also on the board of EyeD Pharma SA and Hyloris Pharmaceuticals SA and Principal at Bio Ensemble Ltd.

She previously held the position of President of Dey Laboratories, Inc., President for Mylan Specialty LP, President for Mylan Technologies, Inc., Vice President-CNS Marketing at Forest Laboratories, Inc., Vice President at Mylan Laboratories, Inc., President-Specialty Pharmaceutical Division at Mylan, Inc., Global Director-Cardiovascular at Pharmacia, Inc. and Vice President-Global Business Development at Allergan Ltd. (Ireland).

She received a doctorate from the University of British Columbia, a doctorate from the University of Wisconsin and an MBA from Rutgers State University of New Jersey.